Toast, Inc. TOST 深 沪
已收盘 10-31 16:00:00 美东时间
36.14
+1.750
+5.09%
华盛通- 最 高36.47
- 今 开35.07
- 成交量 1170.13万股
- 最 低 35.07
- 昨 收 34.39
- 总市值 210.70亿
- 52周最高 49.66
- 市盈率 静 1122.36
- 换手率 2.01%
- 52周最低 28.1221
- 委 比 72.92%
- 总股本 5.83亿
- 历史最高 69.93
- 量 比 1.55
- 振 幅 4.07%
- 历史最低 11.91
- 每 手 1
- 风险率 4.19%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Fiserv stock extends decline as details of strategy overhaul, guidance reset emerge
Fiserv (FI) stock fell 7.1% in Thursday afternoon trading, as a media report disclosed that the company's small-merchant customers were getting fed up with the extra fees attached to the Clover paymen...
10-31 02:04
Citi initiates coverage of 20 fintechs, IT services providers
Citi Research launched coverage on 20 payment processors and IT services providers with Buy and Neutral ratings. Below are the stocks that were newly rated: Visa (V) (VISA:CA) - Buy Mastercard (MA) (M...
10-24 01:09
美股大行评级 | 超配！万事达、Visa、Block获多家机构首予评级；奈飞、德州仪器遭多家机构下调目标价
今日重点评级关注：Canaccord Genuity：维持ATAI Life Sciences"买入"评级，目标价从11美元升至14美元；麦格理：维持Cleanspark"跑赢大市"评级，目标价从20美元升至30美元
10-23 10:06
Microsoft, Toast, Charles Schwab And A Big Bank On CNBC's 'Final Trades'
Capital Area Planning Group's Malcolm Ethridge picked Microsoft, which will release Q1 earnings results on Wednesday, Oct. 29.
10-17 19:38
美股大行评级 | NTSK、STUB、WBI获多个机构首予评级；高盛上调雅诗兰黛(EL)评级至"买入"，目标价从76美元升至115美元
今日重点评级关注：花旗：维持Arcus Biosciences"买入"评级，目标价从47美元升至54美元；HC Wainwright & Co.：上调Karyopharm Therapeutics评级至"买入"，目标价15美元
10-14 09:56
Goldman Sachs Maintains Neutral on Toast, Lowers Price Target to $41
Goldman Sachs analyst Will Nance maintains Toast (NYSE:TOST) with a Neutral and lowers the price target from $51 to $41.
10-14 01:38
美股大行评级 | 潜在涨幅4347.41%！Ascendiant Capital上调PAVmed目标价至20美元，维持"买入"评级
今日重点评级关注：Ascendiant Capital：维持PAVmed"买入"评级，目标价从19美元升至20美元；Ascendiant Capital：维持Plus Therapeutics"买入"评级，目标价从20.5美元升至21美元
10-07 15:04
美股月度涨跌榜 | 华纳兄弟探索频道9月飙升近68%，传派拉蒙天空舞者拟筹备收购该公司；核电股Oklo9月大涨51%
华纳兄弟探索频道9月飙升近68%，传派拉蒙天空舞者拟筹备收购该公司；核电股Oklo9月大涨51%，特朗普政府正寻求建设大型电力项目，以满足AI发展需求>>
10-02 18:30
美股大行评级 | 潜在涨幅162.68%！Ocular Therapeutix获JMP证券升目标价至29美元，维持"跑赢大市"评级
今日重点评级关注：JMP证券：维持Ocular Therapeutix"跑赢大市"评级，目标价从20美元升至29美元；汇丰银行：上调Banco BBVA Argentina评级至"买入"，目标价从21美元下调至17美元
10-02 15:08
Breaking Down Toast: 11 Analysts Share Their Views
In the preceding three months, 11 analysts have released ratings for Toast (NYS...
10-02 03:01
